Internal study validity - potential for bias
|
|
Evaluation criteria |
|
How well were the criteria addressed? |
|
|
|
Quality*
+ ~ x nr |
Participants |
|
Eligibles: inclusion and exclusion criteria:
-Sufficient detail? |
|
Participants were: |
1) |
Chinese men and women |
2) |
Age group 35 to 64 |
|
16 centres in 11 provinces of China
were selected non-randomly in 1992 and 1993, inclusion criteria
of the centres include: |
|
1) |
Having taken part in the Sino-MONICA project |
2) |
Being able to conduct the study |
There was over-representation in the
urban areas (80.3% of participants) |
|
For the addition of 3118 participants
from Beijing in 1996 and 1999, the inclusion criteria were not
stated. |
|
Exclusion criteria was persons with
history of myocardial infarction or angina pectoris (504 excluded).
|
|
|
~ |
|
|
- |
Applied consistently (e.g. if multiple cohorts or multi-centre
study)? |
|
Yes |
|
+ |
|
|
- |
Were eligibles at a common point in the course of their
condition? |
|
Yes, all with no prior CHD. |
|
+ |
|
|
- |
If not, were differences addressed in analyses/interpretation
(e.g. stratified analyses)? |
|
Not done |
|
nr |
|
|
Participant selection from eligibles:
|
- |
|
Sufficient detail on selection process/strategy? |
|
|
At each of the 16 centres, stratified random sampling
for each sex and 10-year age group was performed, but randomization
process was not described in detail. |
|
~ |
|
|
- |
Selection process appropriate to study objectives
(e.g. representative sample / consecutive cases)? |
|
Yes, the selection process by stratified random sampling
for each sex and 10-year age group was appropriate. |
|
+ |
|
|
% eligibles selected who participated? |
|
82% |
|
+ |
Exposures and comparisons |
|
Exposures (e.g. predictive / prognostic /
risk / descriptive factors) and Comparison definitions:
-Sufficient detail?
|
|
Yes, considerable details given according to the WHO-MONICA
protocol for risk factor surveys. |
|
+ |
|
|
- |
If appropriate, was there a comparison group? |
|
Not applicable |
|
nr |
|
|
- |
Objective and valid measurements? |
|
Yes, well defined for all risk factors. The stratification
of blood pressure, diagnostic criteria of diabetes were deliberately
defined according to the Framingham model to ensure comparability.
|
|
+ |
|
|
- |
Applied consistently to all participants? |
|
No clear description on who did the measurements or quality
assurance to ensure consistent application of measurements to all
participants. Potential bias. |
|
~ |
|
|
Were exposure group (EG) and comparison groups
(CG) similar at baseline? |
|
Comparison group not applicable here. |
|
nr |
|
|
If groups not similar, were differences addressed
in analyses / interpretation (e.g. multivariate analyses)? |
|
Not applicable because no comparison group. |
|
nr |
|
|
Were there likely to be residual differences
between EG and CG that could have important effects on outcomes (i.e.
confounding)? |
|
Not applicable because no comparison group. |
|
nr |
|
|
Was exposure / comparison re-measured during
follow-up? |
|
No, only a baseline survey on the risk factor was conducted.
|
|
nr |
|
|
Did any of CG become exposed during follow-up
(contamination)? What %? |
|
Not applicable because no comparison group. |
|
nr |
|
|
Did any of EG become unexposed or receive
the comparison during follow-up (contamination)? %? |
|
No, the risk factor profile of a participant was defined
at the beginning of the study. |
|
+ |
|
|
Was there sufficient contamination to cause
important bias?
Was this addressed? |
|
Not applicable |
|
nr |
|
|
Aside from Exp/Comp were EGs and CG treated
equally during follow-up? |
|
Presumably yes |
|
+ |
|
|
Was there sufficient co-intervention to cause
important bias? |
|
No |
|
+ |
|
|
|
|
|
|
|
Outcomes and time |
|
Outcome definitions: |
- |
|
Sufficient detail (could be replicated)? |
|
|
Yes, diagnosis of "hard" CHD events was according
to the WHO-MONICA project. Trained physicians were sent to visit the
patient or relatives, review the hospital records and complete a standard
event form. The form was sent to the collaborating centre and reviewed
by a group of investigators. |
|
+ |
|
|
- |
Objective and valid measurements? |
|
Physicians making the diagnosis were trained before the
study started and tested every 2 years. 20% of cases were verified
by investigators from the collaborating centre. |
|
+ |
|
|
- |
Assessed blind to Exp / Comp classification or to their
predictive/prognostic significance? |
|
Physicians in the provincial collaborating centre were
not blinded. Investigators in the Beijing collaborating centre who
reviewed the standard event forms were also not blinded to the risk
factors. |
|
X |
|
|
- |
Applied consistently (e.g. if multi-centre study)? |
|
Presumably yes |
|
+ |
|
|
Was follow-up long enough to detect important
effects? |
|
Long enough original 27003 participants (10 years) not
for the additional 3118 participants followed up from 1996 to 1999.
|
|
+/~ |
Analyses |
|
Were all participants initially allocated,
accounted for at study conclusion? |
|
No |
|
~ |
|
|
What was the % lost to follow-up? |
|
For original cohort (27003 participants) 1992-1995: 6%
lost. At each stage of study? From 1996 onward: 38.7% lost because
of ceasing of 6 centres on completion of national research project.
1996-2002: remaining 16552 participants, 14% lost. |
|
~ |
|
|
|
|
3118 Beijing participants from 1996: 14% lost. |
|
|
|
|
|
|
65.3% of the total cohort remained at the end of the study. |
|
|
|
|
Was loss to follow-up sufficient to cause
important bias? |
|
A separate model was created to assess the effect of drop-out.
The total person-years of follow-up and CHD events were reduced and
the 95% CIs for some risk factor categories were wider after the exclusion
of the participants who dropped out. |
|
+ |
|
|
|
|
The bias was properly assessed, and the RRs, 10-year CHD
rates and prediction capabilities did not differ from the current
cohort. There could be bias but the effect should be slight. |
|
+ |
|
|
Were all participants analyzed in groups they
were initially allocated to (intention-to-follow)? |
|
Presumably yes |
|
+ |
Summary Quality Score for validity: how well
did the study minimize bias?(+ or ~ or x) |
|
|
|
+/~ |
*Criteria quality scores: += good, ~ =
okay, x = poor, nr = not reported |